Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-29xt8nhNot yet recruiting
Open-label, single-arm trial of etonogestrel in pregnancy, sponsored by Santa Casa de Porto Alegre. Primary endpoint: Change in kidney graft function. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-29xt8nh.